Bunkerhill Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 44)
Bunkerhill Health logo

Bunkerhill Health

EmergingHealthcare

Medical Imaging AI

Bunkerhill Health is a medical AI company using computer vision to automatically detect and triage critical findings in CT scans, prioritizing urgent cases for faster radiologist review. HQ: San Francisco.

AI VisibilityBeta
Overall Score
C44
Category Rank
#327 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
50
Perplexity
49
Gemini
43

About

Bunkerhill Health is a medical AI company developing computer vision software that automatically analyzes CT scans to detect critical, time-sensitive findings — stroke, pulmonary embolism, aortic dissection, intracranial hemorrhage — and alerts the care team immediately for priority radiologist review. The company's software integrates with hospital picture archiving and communication systems (PACS), monitoring the incoming scan queue and flagging studies with potential emergency findings for immediate radiologist attention rather than processing in standard queue order.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

44
Overall Score
90
#327
Category Rank
#2
78
AI Consensus
83
stable
Trend
stable
50
ChatGPT
92
49
Perplexity
93
43
Gemini
89
42
Claude
96
47
Grok
95

Key Details

Category
Medical Imaging AI
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Bunkerhill Health
Medical Imaging AI

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.